[1]
Eikesdal, H.P. et al. 2014. TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy. Acta Oncologica. 53, 10 (Oct. 2014), 1347–1355. DOI:https://doi.org/10.3109/0284186X.2014.922215.